Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyJens G. Lohr, Keith Stockerl-Goldstein, Petar Stojanov et al.|Cancer Cell|2014Cited by 1k
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingJens G. Lohr, Todd R. Golub, Petar Stojanov et al.|Proceedings of the National Academy of Sciences|2012Cited by 990
The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1.Peter Altevogt, E C Butcher, Marcus Hubbe et al.|The Journal of Experimental Medicine|1995Cited by 88
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J. Hanna, Robert I. Haddad, Jens G. Lohr et al.|Oral Oncology|2021Cited by 51
High Throughput Sequencing-Based Pathogen Discovery In Multiple MyelomaAkinyemi I. Ojesina, Matthew Meyerson, Chandra Sekhar Pedamallu et al.|Blood|2013Cited by 0